Center for Immunotherapy
Novosibirsk — Kaliningrad — Moscow — Irkutsk
Cell transplantation
Neurological disorders
- Spinal cord injury
- Acute craniocerebral (brain) injury (coma)
- Acute craniocerebral (brain) injury (long-term consequences)
- Stroke
- Cerebral palsy
Hepatic diseases
Bone and articular diseases
Vascular disorders
The Mission
In 1995 the scientific research group specializing in development of medical cellular technologies was organized at the Institute of Clinical Immunology of Russian Academy of Medical Sciences. Later, this group was reformed into the Laboratory of Cellular Biotechnology that became a base for setting up the Center for Immunotherapy & Ñellular Technologies (CICT). At present this Center is the informal association of the foremost medical institutions in Russia, concerned with putting new immunotherapeutic and cellular technologies into clinical practice.
An xenogenous polyantigenic cancer vaccine has been developed and clinically tested in CICT for the first time in the world. for more information
The new method of preparing polyclonal T-cell vaccines has been developed in CICT for treating patients with autoimmune diseases. for more information
The regimens of regenerative immunotherapy have been developed in CICT for treating patients with different chronic diseases. for more information
CICT is actively developing stem cell-based technologies aimed at the treatment for the most problematic human diseases. for more information
